1. Home
  2. KTTA vs AEON Comparison

KTTA vs AEON Comparison

Compare KTTA & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

SELL

Current Price

$0.48

Market Cap

15.6M

Sector

Health Care

ML Signal

SELL

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

HOLD

Current Price

$0.12

Market Cap

13.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
AEON
Founded
2020
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
13.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
KTTA
AEON
Price
$0.48
$0.12
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $1.82
AVG Volume (30 Days)
★ 1.4M
809.4K
Earning Date
11-13-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 77.07
N/A
EPS
N/A
★ N/A
Revenue
★ $486,559.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3130.37
N/A
52 Week Low
$0.32
$0.11
52 Week High
$2.06
$1.45

Technical Indicators

Market Signals
Indicator
KTTA
AEON
Relative Strength Index (RSI) 49.53 29.39
Support Level $0.42 N/A
Resistance Level $0.57 $0.33
Average True Range (ATR) 0.08 0.03
MACD -0.00 -0.01
Stochastic Oscillator 48.59 10.50

Price Performance

Historical Comparison
KTTA
AEON

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Share on Social Networks: